Navigation Links
EMD Serono Exclusive Supporter of Newly Launched Multiple Sclerosis Resource Centre
Date:10/1/2013

ROCKLAND, Mass., Oct. 1, 2013 /PRNewswire/ -- EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, is the founding supporter of the newly launched Multiple Sclerosis (MS) Resource Centre website (http://multiplesclerosis.elsevierresource.com/) developed by Elsevier, B.V. of the Netherlands. EMD Serono helped established the MS Resource Centre through a $250,000 unrestricted grant to Elsevier, B.V. to develop and launch the website, which will provide high quality, balanced and scientifically valid information to health care providers.

(Logo: http://photos.prnewswire.com/prnh/20121220/SF32295LOGO-a)

(Logo: http://photos.prnewswire.com/prnh/20121220/SF32295LOGO-b)

"EMD Serono is proud to have provided the necessary foundation for Elsevier to develop this website that aims to provide clinicians with access to the latest literature on multiple sclerosis," said Thorsten Eickenhorst, MD, PhD, MBA, Senior Vice President and Chief Medical Officer at EMD Serono, Inc. "EMD Serono is committed to supporting organizations that invest in the understanding and treatment of multiple sclerosis, and share our goal of improving patient care."

The MS Resource Centre is a medical education platform for healthcare providers hosted by Elsevier's new peer-reviewed journal, Multiple Sclerosis and Related Disorders (http://www.msard-journal.com/). This website will afford the MS community numerous benefits, including access to taped lectures, video interviews with leaders in the field, a congress planner and key articles reporting on breakthrough findings by highly regarded authors.  Timothy Vartanian, MD, PhD, Professor at the Brain and Mind Research Institute and the Department of Neurology, Weill Cornell Medical College, Cornell University is the Editor of the Resource Center.

The site will be launched at the ECTRIMS 2013 conference, October 2 – 5, in Copenhagen, Denmark.  For more information, congress delegates should stop by the Elsevier Exhibit Booth at ECTRIMS.

About EMD Serono, Inc.
EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, is a leader in the US biopharmaceutical arena, integrating cutting-edge science with unparalleled patient support systems to improve people's lives. The company has strong market positions in neurodegenerative diseases, endocrinology and in reproductive health. In addition, EMD Serono is growing its expertise and presence in the area of oncology, with more than 15 projects currently in development. With a clear focus on the patient and a leadership presence in the biopharmaceutical industry, EMD Serono's US footprint continues to grow, with approximately 1,000 employees around the country and fully integrated commercial, clinical and research operations in the company's home state of Massachusetts.

For more information, please visit www.emdserono.com 

About Merck KGaA
Merck is a leading pharmaceutical, chemical and life science company with total revenues of € 11.2 billion in 2012, a history that began in 1668, and a future shaped by approx. 38,000 employees in 66 countries. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.

For more information, please visit www.merckserono.com or www.merckgroup.com


'/>"/>
SOURCE EMD Serono
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Merck Serono progresse à la huitième place dans le classement Access to Medicine Index
2. EMD Serono Expands the Grant for Fertility Innovation (GFI) Program to Include U.S. Investigators
3. Alliqua Becomes Exclusive Distributor of sorbion-Branded Wound Products in the Americas Through Agreement with Carolon
4. BioLife Solutions and SAVSU Technologies Announce Exclusive Distribution Agreement
5. B. Riley Exclusive Financial Advisor to Mirth Corporation in Connection with its Corporate Sale to Quality Systems, Inc.
6. Debiopharm Group and TCG Lifesciences Ltd. Enter into an Exclusive Research Agreement to Develop a Novel Class of Antibiotics, a New Strategic Therapeutic Area for Debiopharm
7. Sanofi US and POZEN Sign Exclusive License Agreement for the Commercialization of PA8140/PA32540 Tablets in the U.S.
8. Eisai Inc. Announces Non-Exclusive Licensing Agreement with Generic Drug Manufacturer to Provide Generic Version of donepezil HCl 23 mg
9. Digirad Signs Exclusive International Distribution Agreement with Dilon Diagnostics
10. GUARDaHEART to Host Exclusive Event focused on Targeting Heart Disease in Celebration of the World Heart Day Mission
11. BSI Offers Medical Device Manufacturers Exclusive Access to Global Panel of Experts in 3 Key Cities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... REDWOOD CITY, Calif., Feb. 10, 2016   Genomic Health, Inc. ... progress for the quarter and year ended December 31, 2015. ... in the fourth quarter of 2015, compared with $69.1 million in ... a constant currency basis, revenue increased 9 percent compared with the ... --> U.S. revenue was $63.9 million in the fourth ...
(Date:2/10/2016)... --> --> This press release is intended for U.S. and EU ... .  --> A separate press release has been prepared for use in ... continues to strengthen its presence in Japan ... strengthen its presence in Japan   ... strengthen its presence in Japan   ...
(Date:2/10/2016)... DIEGO , Feb. 10, 2016 ... gene therapy manufacturing, and Renova™ Therapeutics, a biopharmaceutical company ... other chronic diseases, have entered into a Manufacturing Services ... cGMP-grade RT-100 (Ad5.hAC6) Drug Product for use in Renova,s ... --> This relationship will leverage Lonza,s expertise ...
Breaking Medicine Technology:
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... and Video Remote Interpreting (VRI) within Healthcare, recently partnered with Heart City ... interpreting (VRI). , For nearly 23 years, Heart City Health Center has provided ...
(Date:2/10/2016)... ... February 10, 2016 , ... Compliancy Group ... associations of medical professionals throughout the country. The Guard was specifically designed to ... and procedures, employee training, regulatory updates, and compliance coaching. , In addition to ...
(Date:2/10/2016)... ... 2016 , ... Emergency rooms provide emergency care to stabilize critical health issues, ... with dental emergencies at risk of losing a tooth or their smiles. Dr. Marine ... Common dental emergencies include:, , Avulsed or knocked-out teeth , ...
(Date:2/10/2016)... ... February 10, 2016 , ... Dr. Peyman ... is now offering a variety of comprehensive procedures for facial enhancement. The treatments ... volume restoration, lip enhancement and nasal reshaping. , As a result, patients ...
(Date:2/10/2016)... ... February 10, 2016 , ... Ongoing news of the ravages of traumatic ... to conduct a survey that takes a closer look at cases of TBI being ... and causes of TBI among the aging population, and identifies the challenges associated with ...
Breaking Medicine News(10 mins):